SOP for informed consent template filing – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Sun, 14 Sep 2025 03:43:04 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Essential Documents Before Trial (ICH E6 §8) https://www.clinicalstudies.in/sop-for-essential-documents-before-trial-ich-e6-%c2%a78/ Sun, 14 Sep 2025 03:43:04 +0000 ]]> https://www.clinicalstudies.in/?p=7017 Read More “SOP for Essential Documents Before Trial (ICH E6 §8)” »

]]>
SOP for Essential Documents Before Trial (ICH E6 §8)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-essential-documents-before-trial-ich-e6-section-8”
},
“headline”: “SOP for Essential Documents Before Trial (ICH E6 §8)”,
“description”: “This SOP defines the required essential documents to be filed before the initiation of a clinical trial, in compliance with ICH E6 §8 and regulatory requirements of FDA, EMA, CDSCO, and WHO. It includes procedures for filing protocols, approvals, IB, consent templates, CVs, training records, contracts, and regulatory correspondence.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Essential Documents Before Trial (ICH E6 §8)

SOP No. CR/OPS/076/2025
Supersedes NA
Page No. 1 of 36
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to describe the management, filing, and verification of essential documents required before the initiation of a clinical trial, in accordance with ICH E6 §8, GCP, and global regulatory authority expectations. These documents collectively demonstrate trial preparation, regulatory compliance, and readiness for initiation.

Scope

This SOP applies to all clinical trials sponsored or managed by the organization and covers sponsor, CRO, investigator site, and vendor responsibilities for generating, collecting, and filing essential documents before trial initiation. It includes regulatory approvals, contracts, study-specific records, and readiness assessments.

Responsibilities

  • Sponsor: Ensures all pre-trial essential documents are collected, filed, and verified.
  • CRO: Collects and files documents on behalf of sponsor when delegated.
  • Investigator: Provides site-level documents such as CVs, training records, and ISF setup.
  • QA: Conducts pre-trial TMF review and audit readiness check.
  • Regulatory Affairs: Provides regulatory submissions and approvals.
  • Clinical Operations: Ensures all contracts, logs, and templates are filed.

Accountability

Sponsor is accountable for ensuring completeness and accuracy of essential documents before trial start. QA is accountable for verifying readiness, while CRO and investigators are responsible for document provision.

Procedure

1. Protocol and Related Documents
1.1 File final protocol, protocol amendments (if any), and synopsis in TMF/ISF.
1.2 File protocol signature page with sponsor, investigator, and approval authority signatures.
1.3 File Investigator Brochure (IB) and any updates.

2. Regulatory and Ethics Approvals
2.1 File EC/IRB approval letter for protocol, informed consent, and recruitment materials.
2.2 File regulatory authority approvals (e.g., IND, CTA, CTN approval letters).
2.3 File correspondence with authorities in Regulatory Correspondence Log (Annexure-1).

3. Informed Consent Templates
3.1 File approved informed consent form templates, including local language versions.
3.2 Ensure that assent forms for pediatric trials are included.
3.3 Maintain Consent Template Log (Annexure-2).

4. Site and Investigator Documentation
4.1 File CVs and medical licenses for PI and sub-investigators.
4.2 File GCP and protocol training certificates.
4.3 File Delegation of Authority Log (Annexure-3).

5. Contracts and Agreements
5.1 File CRO, vendor, and site contracts with scope of work, timelines, and compliance clauses.
5.2 File financial disclosure forms of investigators.
5.3 File insurance and indemnity certificates.

6. Facility and Laboratory Documentation
6.1 File site qualification checklist and initiation visit reports.
6.2 File laboratory certifications, accreditations, and normal ranges.
6.3 File equipment calibration and maintenance certificates.

7. Investigational Product Documentation
7.1 File regulatory approvals for labeling and import/export licenses.
7.2 File IP labeling and accountability plan.
7.3 File IP shipping and storage arrangements documentation.

8. Verification and Quality Control
8.1 TMF Administrator maintains Essential Documents Checklist (Annexure-4).
8.2 QA verifies all documents are filed before initiation meeting.
8.3 Missing documents must be tracked in Pre-Trial Document Gap Log (Annexure-5).

Abbreviations

  • SOP: Standard Operating Procedure
  • TMF/ISF: Trial Master File / Investigator Site File
  • PI: Principal Investigator
  • EC/IRB: Ethics Committee / Institutional Review Board
  • IB: Investigator Brochure
  • CRO: Contract Research Organization
  • IP: Investigational Product
  • QA: Quality Assurance

Documents

  1. Regulatory Correspondence Log (Annexure-1)
  2. Consent Template Log (Annexure-2)
  3. Delegation of Authority Log (Annexure-3)
  4. Essential Documents Checklist (Annexure-4)
  5. Pre-Trial Document Gap Log (Annexure-5)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, TMF Administrator
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Quality

Annexures

Annexure-1: Regulatory Correspondence Log

Date Authority Subject Outcome Filed By
10/09/2025 CDSCO CTA Approval Approved Regulatory Affairs

Annexure-2: Consent Template Log

Version Language Approval Date Approved By
v1.0 English 05/09/2025 EC
v1.0 Hindi 06/09/2025 EC

Annexure-3: Delegation of Authority Log

Name Role Task Delegated Date Assigned Signature
Dr. Neha Verma PI Overall Study Oversight 01/09/2025 Signed
Arjun Patel Coordinator Consent Process 01/09/2025 Signed

Annexure-4: Essential Documents Checklist

Document Status Remarks
Final Protocol Filed Approved version
Investigator Brochure Filed v5.0
EC Approval Filed Initial approval

Annexure-5: Pre-Trial Document Gap Log

Date Document Gap Identified Action Taken Status
12/09/2025 Lab Certification Pending renewal Requested from lab Open

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Quality

For more SOPs visit: Pharma SOP

]]>